Boston, Massachusetts, USA – April 23, 2025 – ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced the launch of its Shared Success Model – a new, value-first engagement commitment that guarantees automation-driven return on investment (ROI) for pharmaceutical companies. Designed to de-risk technology investments, this model aligns ArisGlobal’s success directly with its customers’, using proven solutions powered by LifeSphere® NavaX™.
“At ArisGlobal, we believe value should not only be promised – it should be delivered.” said Aman Wasan, Chief Executive Officer, ArisGlobal. “Our Shared Success Model ensures our partners realize measurable efficiency gains and cost savings – and we stand behind those outcomes. With NavaX, we’re delivering real automation at scale; not experiments or pilots, but enterprise-ready systems transforming safety and regulatory workflows today.”
A New Model for Automation Adoption
In an industry where more than 75% of life sciences companies have experimented with automation, but only 8% have scaled it, the Shared Success Model provides a low-risk, outcome-based alternative. Rather than requiring large upfront investments in emerging technologies, pharma companies can now embrace automation through a model where value is delivered — and success is shared.
This approach is backed by LifeSphere NavaX, ArisGlobal’s Generative AI (GenAI) driven automation engine enabling next generation performance across pharmacovigilance, regulatory, and R&D workflows.
A Strategic Partnership for the Future
With the Shared Success Model, ArisGlobal delivers more than just technology — it offers a tested path to operational transformation, backed by contractual commitments to results. It is designed for leaders who want to accelerate innovation, strengthen compliance, and scale automation with confidence.
Recent product launches, including the Agentic MedDRA Coding Agent — which uses context-aware AI to streamline adverse event coding — and NavaX Insights for data-driven decision-making, reinforce ArisGlobal’s commitment to tangible, scalable outcomes.
About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.
